A Repository to Study Host-Microbiome Interactions in Health and Disease
NCT ID: NCT05656378
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2023-03-09
2032-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The microbiome is the bacteria and other microorganisms that live inside and on the body. The microbiome is important for our health. Researchers study how the microbiome help people stay healthy. They study how the microbiome affects the body when people get sick. To do this research, they need samples of the microbiome living on the bodies of many people. The purpose of this natural history study is to collect microbiome samples in a repository. These samples will be used for future research.
Objective:
To collect microbiome samples from the body that can be used for future research.
Eligibility:
People of any age. Only those older than 3 years will be seen at the NIH clinic.
Design:
Participants will fill out a questionnaire. Topics will include their medical history and foods they eat.
Participants will be asked to give 1 or more of the following:
Stool, urine, saliva, vaginal fluid, and breastmilk. These samples can be collected at home and sent to the researchers.
Cells from participants cheek, nose, mouth, skin, rectum, and/or vagina. The cells may be collected by rubbing the area with a sterile cotton swab. These procedures can also be done at home.
Blood. Blood may be drawn using a needle inserted into a vein in the arm. For young children, blood may be collected by a prick on the heel or finger.
Intestinal tissue samples. These may be collected from participants who are having an endoscopy or colonoscopy for other reasons.
Skin tissue samples. These may be collected from participants who are having biopsies for other reasons.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The human microbiome and host response to the microbiome play a key role in human health and disease. The Clinical Microbiome Unit focuses on clinical microbiome intervention trials to improve human health. This is a sample collection repository protocol to provide samples needed for validation of assays and techniques vital to the success of designing and analyzing interventional trials.
Primary Objective:
To collect biological specimens to assess host microbiome response for 1) assay validation, 2) optimization of techniques for collection, storage, processing and analyzing samples, 3) control samples for research tests in other studies, and 4) identification of potential targets from which clinical trials can be designed to better understand or mitigate microbiome-associated diseases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Cohort
Participants aged \>0 years with no upper age limit, both healthy volunteers and those with previously known and unknown disease states
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged \>0 years. Only participants \>3 years old will be seen at the NIH CC.
* Willing to allow biological samples and data to be stored for future research.
* Willing to provide at least one of the requested biospecimens.
Exclusion Criteria
* For additional gastrointestinal and skin biopsies only, individuals on blood thinners unless they have already been stopped for the procedure.
* For additional gastrointestinal biopsies only, individuals who have a history of gastrointestinal perforation with endoscopic biopsies will be excluded from the collection of additional gastrointestinal biopsies for the repository.
* For additional gastrointestinal biopsies only, healthy children (\<18 years old).
* For skin biopsies only, individuals who have a history of keloid formation.
* For vaginal swabs and vaginal fluid only, individuals who have not started menses.
* For breast milk only, non-lactating individuals.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suchitra K Hourigan, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001146-I
Identifier Type: -
Identifier Source: secondary_id
10001146
Identifier Type: -
Identifier Source: org_study_id